Phase 1a/b study of monoclonal antibody CAEL-101 (11-1F4) in patients with AL amyloidosis

Edwards, C. V., Rao, N., Bhutani, D., Mapara, M., Radhakrishnan, J., Shames, S., Maurer, M. S., Leng, S., Solomon, A., Lentzsch, S., & Eisenberger, A. (2021). Phase 1a/b study of monoclonal antibody CAEL-101 (11-1F4) in patients with AL amyloidosis. Blood, 138(25), 2632–2641. https://doi.org/10.1182/blood.2020009039

Authors:

Camille Vanessa Edwards

Nisha Rao

Divaya Bhutani

Markus Mapara

Jai Radhakrishnan

Sofia Shames

Mathew S. Maurer

Siyang Leng

Alan Solomon

Suzanne Lentzsch

Andrew Eisenberger